2023 - Research.com Medicine in Spain Leader Award
Internal medicine, Heart failure, Endocrinology, Cardiology and Fibrosis are his primary areas of study. His study in Internal medicine focuses on Myocardial fibrosis, Left ventricular hypertrophy, Muscle hypertrophy, Hypertensive heart disease and Angiotensin II. His Heart failure research is multidisciplinary, incorporating elements of Lysyl oxidase, Heart disease, Furosemide and Intensive care medicine.
His study looks at the relationship between Endocrinology and fields such as Ventricle, as well as how they intersect with chemical problems. In his study, which falls under the umbrella issue of Cardiology, Heart rate, Creatinine and Cardiac cycle is strongly linked to Diastole. His work carried out in the field of Fibrosis brings together such families of science as Cardiac function curve and Ventricular remodeling.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Endocrinology, Heart failure and Fibrosis. Myocardial fibrosis, Left ventricular hypertrophy, Essential hypertension, Blood pressure and Hypertensive heart disease are among the areas of Internal medicine where Javier Díez concentrates his study. His work deals with themes such as Ventricle and Muscle hypertrophy, which intersect with Left ventricular hypertrophy.
Javier Díez has researched Cardiology in several fields, including Cardiotrophin 1 and Diastole. His study ties his expertise on Superoxide together with the subject of Endocrinology. His study in the field of Cardiac function curve and Heart failure with preserved ejection fraction also crosses realms of In patient and N-terminal telopeptide.
His primary areas of study are Internal medicine, Heart failure, Cardiology, Fibrosis and Myocardial fibrosis. The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Endocrinology. His study in Endocrinology focuses on Left ventricular hypertrophy in particular.
His Heart failure research includes themes of Biomarker and Gastroenterology. His Fibrosis research incorporates elements of Hypertensive heart disease, Myocarditis, Inflammation, Blood pressure and Dilated cardiomyopathy. His Myocardial fibrosis research focuses on Circulating biomarkers and how it connects with Left ventricular structure.
His main research concerns Heart failure, Internal medicine, Myocardial fibrosis, Cardiology and Fibrosis. In general Heart failure, his work in Cardiac function curve is often linked to Action linking many areas of study. Internal medicine is a component of his Hazard ratio and Galectin-3 studies.
Javier Díez interconnects Endocrinology and Diastole in the investigation of issues within Myocardial fibrosis. His work deals with themes such as Pressure overload, Angiotensin II, Dilated cardiomyopathy and Hepatic stellate cell, which intersect with Diastole. His Fibrosis research includes themes of Muscle hypertrophy and Myocarditis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Charles A. Herzog;Charles A. Herzog;Richard W. Asinger;Richard W. Asinger;Alan K. Berger;David M. Charytan.
Kidney International (2011)
European Stroke Initiative Recommendations for Stroke Management-update 2003.
Gunnel E. Carlsson;Anders Möller;Christian Blomstrand;Takashi Ueda.
Cerebrovascular Diseases (2003)
Myocardial remodeling after infarction: the role of myofibroblasts
Susanne W. M. van den Borne;Javier Diez;W. Matthijs Blankesteijn;Johan Verjans.
Nature Reviews Cardiology (2010)
Distinct DNA methylomes of newborns and centenarians
Holger Heyn;Ning Li;Humberto J. Ferreira;Sebastian Moran.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.
Javier Díez;Ramón Querejeta;Begoña López;Arantxa González.
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Carolyn Y. Ho;Begoña López;Otavio R. Coelho-Filho;Neal K. Lakdawala.
The New England Journal of Medicine (2010)
Oxidative Stress in Arterial Hypertension: Role of NAD(P)H Oxidase
Guillermo Zalba;Gorka San José;María U. Moreno;María A. Fortuño.
Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats
Guillermo Zalba;Francisco J. Beaumont;Gorka San José;Ana Fortuño.
Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease
Ramón Querejeta;Nerea Varo;Begoña López;Mariano Larman.
Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
Ramón Querejeta;Begoña López;Arantxa González;Eloy Sánchez.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: